ArticleProceedings of the National Academy of Sciences of the United States of America2020

REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks.

Nimrat Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.